Company profile
Precipio, Inc.
NASDAQ: PRPO · Healthcare · Medical - Diagnostics & Research
#528 of 1,418 Healthcare companies by revenue72nd-percentile growth
EA Score
69BFH 73DQ 65GM 75SS 52
v0.1 · 65/100 weight · provisional
↑ disclosure history, Piotroski F · ↓ filing timeliness, listing tenure
Methodology →Revenue TTM
$26.1M
Rev growth YoY (TTM)
+34.8%
Net income (FY)
-$363.0k
Employees
61
as of 2026-08-20
Market cap
$49.7M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$24.2M$24.2M2025
Net income-$363.0k-$363.0k2025
Operating income-$1.2M-$1.2M2025
Total assets$21.3M$21.3M2025
Liabilities$6.8M$6.8M2025
Equity$14.6M$14.6M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Service revenue, net70%
Diagnostic Testing30%
By geography
Not disclosed.
The read
What is Precipio, Inc.’s revenue?
Precipio, Inc. booked $24.2M in FY2025 revenue, growing 31% year over year — faster than most Healthcare companies we track, at a -1.5% net margin.
Peers · Healthcare
Metagenomi, Inc. Common Stock40DIonic Brands Corp.——Halo Collective Inc.——Alumis Inc.35DCovalon Technologies Ltd.78B+Wellgistics Health, Inc.19DNeighbors
New Haven →Key facts
CEOIlan Danieli
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersNew Haven, CT
ExchangeNASDAQ: PRPO
Employees61
IPO date2017-06-30
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.